ArticleNucleic acid therapeutics2017

A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma.

Gary A Clawson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.